Jonathan India

Contract Value Index (CVI)

Jonathan India's value math nets a D- Contract Value Index relative to comparable second base deals. At $8M annually on a one-year contract, India is being paid in the range of a solid-to-above-average starter, yet his 2026 production—a .167 average with 13 strikeouts across 17 games before season-ending shoulder surgery—represents below-average output that does not justify that price point. The central problem is simple: the Royals are absorbing a full-market salary for a player whose durability has collapsed and whose on-field return has been minimal, making this a clear overpay relative to what he is actually delivering. India's situation is compounded by his career stage (a 29-year-old sixth-year veteran entering the back half of his prime) and the recent revelation of a chronic five-year injury history culminating in shoulder subluxation surgery, meaning the Royals are not betting on near-term recovery or long-term bounce-back value—they are managing around an asset that has become unreliable. The organization's recent flurry of pitching acquisitions and roster shuffling signals active management around his absence rather than investment in his return, further cementing that this contract represents sunk cost rather than current strategic value. Media framing has shifted decisively toward skepticism about India's future role and durability, and that pessimism is warranted: the team is paying mid-tier starter money for an injury-prone player who is no longer part of the competitive equation, making this one of Kansas City's poorer current-year value propositions.

Performance Analysis